Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study.
about
Surgical Management of Clostridium difficile ColitisComparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infectionsRecent advances in the understanding of antibiotic resistance in Clostridium difficile infectionAcid suppression and the risk of Clostridium difficile infectionA Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management.Surveillance of infection severity: a registry study of laboratory diagnosed Clostridium difficileThe changing epidemiology of Clostridium difficile infectionsClostridium difficile infection in Italian urban hospitals: data from 2006 through 2011.Outbreak of Clostridium difficile PCR ribotype 027--the recent experience of a regional hospital.Appendicectomy and clostridium difficile infection: is there a link?Physician attitudes toward the use of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection.Enhancing patient safety by reducing healthcare-associated infections: the role of discovery and dissemination.Epidemiology of Clostridium difficile infectionCurrent status of Clostridium difficile infection epidemiologyReduction in Clostridium difficile infection rates after mandatory hospital public reporting: findings from a longitudinal cohort study in Canada.A prospective study to examine the epidemiology of methicillin-resistant Staphylococcus aureus and Clostridium difficile contamination in the general environment of three community hospitals in southern Ontario, Canada.Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolateProcalcitonin levels associate with severity of Clostridium difficile infectionUpregulation of the host SLC11A1 gene by Clostridium difficile toxin B facilitates glucosylation of Rho GTPases and enhances toxin lethality.Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic LocationsThe identification and epidemiology of meticillin-resistant Staphylococcus aureus and Clostridium difficile in patient rooms and the ward environment.Clostridium difficile infection in the community: are proton pump inhibitors to blame?Reducing the risk of severe complications among patients with Clostridium difficile infection.A curated C. difficile strain 630 metabolic network: prediction of essential targets and inhibitors.Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection--an observational cohort study.High Mortality Risk in Chronic Kidney Disease and End Stage Kidney Disease Patients with Clostridium Difficile Infection: A Systematic Review and Meta-analysis.Prevalence of antimicrobial use in a network of Canadian hospitals in 2002 and 2009.The epidemiology of community-acquired Clostridium difficile infection: a population-based studyIncidence and Costs of Clostridium difficile Infections in CanadaRisk factors for recurrent hospital-acquired Clostridium difficile infection in a Japanese university hospital.Hypervirulent Clostridium difficile strains in hospitalized patients, CanadaImpact of Surotomycin on the Gut Microbiota of Healthy Volunteers in a Phase 1 Clinical Trial.Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection.An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model.Binary toxin and death after Clostridium difficile infection.Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta-analysis.Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach.Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge ModelA Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics.
P2860
Q24618413-99387206-F2C1-474E-AB7B-6AFDB90C4C11Q26752760-DDFD17DA-5118-4EA4-B059-2F5C4F6E5A87Q26767079-6FA11343-8324-45D2-8B1D-6AC05EFFFA93Q26823599-3B29A7EC-DBDA-4935-BFE5-649C99A68A5BQ27335693-393225D6-FB9E-47F2-A10F-9BE0FCC48345Q28728656-8C4F66DC-91DE-42FE-B722-A2D9194D11CFQ28750385-7BE97740-FED3-48E7-8F90-2A4ED7B8A718Q30605607-06E30554-B6A6-41A5-A0F2-AA6263239A1DQ31158719-AF6256AF-1BAE-4DCC-BA3B-E0BDF53C1ACFQ33688300-71E34BAA-2E07-4CED-8A3A-54505D2F0F4EQ33810999-6D0628E8-203B-493F-8EA6-716CA19530FAQ33988655-3CAC3EAC-D94E-449F-8BD4-DECB703216A6Q34027474-EF8994C5-448B-4BC9-AB10-CA119307D0BBQ34285444-5CDA6B9B-D974-4857-BC10-4E8B592411D9Q34289281-C12FEF17-3301-413E-87DB-59D1CF1E6B74Q34471021-A3479CAA-777B-4E4D-9742-E62874E98A07Q34562315-2084A6F0-10E8-4ABF-8D91-E8D819F11EC1Q34625689-6CA9A7D6-08AB-4441-ABE9-6B03FB1B9974Q34729613-E725FA33-52AE-4827-8590-2F3C611A7544Q34801846-D6170C79-03DC-46E9-BB13-52984C5ECB6CQ34862890-DB7B2435-DD3B-4C3C-9C44-E12A5D90E3B6Q35031254-FEB9AE39-47E1-4340-980D-9314F8BCF034Q35215637-0B591DB2-1791-4421-8899-DE6CCA370192Q35332572-2F8001D7-49B2-48E2-8373-57EFE8DE2E1EQ35333556-4A17D0D1-F91A-4CF0-A26B-0A3711A9E4B2Q35376007-4E5DEF9F-114D-4360-A433-A798378EFC69Q35383084-5DAD3AF8-62A6-446B-BC42-02647EBF0BF1Q35569879-9D454066-4761-4ADF-8FF9-905FCB2919F6Q35740811-01BEC210-2FA4-44BF-95EB-2893F0721653Q35856280-D8A48E0C-10E3-4FA0-86CC-01BFCB99FA4BQ35866318-0B540A10-65E2-4FF4-A4E6-CF59A7620F76Q35877207-799A3C96-DC35-4728-9C5D-81D47A1EFAE7Q35898582-BB5CF23D-B4DF-4BBD-91DE-9D2DEC6ADB60Q35930922-43AAD6DE-8AF6-4736-AEE5-1C14D6D575CFQ35975135-FC2B7114-0AB8-42C6-B28E-17595D732453Q35980156-ECBEC149-A8AB-41BB-A229-3DF0B6BFB942Q36004544-9CB7A3DD-C7C8-4CAA-AFBE-42F49B2D558DQ36055810-9228A693-4F03-46EE-9F43-100195D855E9Q36060123-42470424-2E64-4D6B-AF6E-3A0CC67B9774Q36091394-92FA8EFE-7ACB-4B60-B577-5D935A877D29
P2860
Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Health care-associated Clostri ...... on Surveillance Program Study.
@en
Health care-associated Clostri ...... on Surveillance Program Study.
@nl
type
label
Health care-associated Clostri ...... on Surveillance Program Study.
@en
Health care-associated Clostri ...... on Surveillance Program Study.
@nl
prefLabel
Health care-associated Clostri ...... on Surveillance Program Study.
@en
Health care-associated Clostri ...... on Surveillance Program Study.
@nl
P2093
P356
P1476
Health care-associated Clostri ...... on Surveillance Program Study.
@en
P2093
Andrew Simor
David Boyd
Denise Gravel
Dorothy Moore
Geoffrey Taylor
James Hutchinson
Mark Miller
Michael Gardam
Michael Mulvey
Sharon Kelly
P304
P356
10.1086/596703
P407
P577
2009-03-01T00:00:00Z